Report Detail
Global PDE Inhibitors Market Insights and Forecast to 2026
- RnM4158660 |
- 25 August, 2020 |
- Global |
- 186 Pages |
- QYResearch |
- Pharma & Healthcare
PDE Inhibitors market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global PDE Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the PDE Inhibitors market is segmented into
PDE5
PDE4
Viagra
Cialis
Levitra
Others
Segment by Application, the PDE Inhibitors market is segmented into
Genitourinary
Cardiovascular Diseases
Dermatological Disorders
Respiratory Diseases
Schizophrenia
Alzheimer’S Disease
Huntington’S Disease
Others
Regional and Country-level Analysis
The PDE Inhibitors market is analysed and market size information is provided by regions (countries).
The key regions covered in the PDE Inhibitors market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and PDE Inhibitors Market Share Analysis
PDE Inhibitors market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in PDE Inhibitors business, the date to enter into the PDE Inhibitors market, PDE Inhibitors product introduction, recent developments, etc.
The major vendors covered:
Hanmi Science Holding
Boehringer Ingelheim
Takeda Pharmaceuticals
AstraZeneca
Bayer
Celgene
Eli Lilly
Pfizer
BioCrea
Dart NeuroScience
Carinopharm
CTC Bio
FORUM Pharmaceuticals
Intra-Cellular Therapies
Omeros Corporation
Medimetriks Pharmaceuticals
NuSirt Biopharma
Palobiopharma
Roivant Sciences
Sagene Pharmaceuticals
Tetra Discovery Partners
Tritech Biopharm
Otsuka
Chiesi Farmaceutici
Verona Pharma
1 Study Coverage
- 1.1 PDE Inhibitors Product Introduction
- 1.2 Market Segments
- 1.3 Key PDE Inhibitors Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global PDE Inhibitors Market Size Growth Rate by Type
- 1.4.2 PDE5
- 1.4.3 PDE4
- 1.4.4 Viagra
- 1.4.5 Cialis
- 1.4.6 Levitra
- 1.4.7 Others
- 1.5 Market by Application
- 1.5.1 Global PDE Inhibitors Market Size Growth Rate by Application
- 1.5.2 Genitourinary
- 1.5.3 Cardiovascular Diseases
- 1.5.4 Dermatological Disorders
- 1.5.5 Respiratory Diseases
- 1.5.6 Schizophrenia
- 1.5.7 Alzheimer’S Disease
- 1.5.8 Huntington’S Disease
- 1.5.9 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global PDE Inhibitors Market Size, Estimates and Forecasts
- 2.1.1 Global PDE Inhibitors Revenue 2015-2026
- 2.1.2 Global PDE Inhibitors Sales 2015-2026
- 2.2 Global PDE Inhibitors, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global PDE Inhibitors Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global PDE Inhibitors Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global PDE Inhibitors Competitor Landscape by Players
- 3.1 PDE Inhibitors Sales by Manufacturers
- 3.1.1 PDE Inhibitors Sales by Manufacturers (2015-2020)
- 3.1.2 PDE Inhibitors Sales Market Share by Manufacturers (2015-2020)
- 3.2 PDE Inhibitors Revenue by Manufacturers
- 3.2.1 PDE Inhibitors Revenue by Manufacturers (2015-2020)
- 3.2.2 PDE Inhibitors Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global PDE Inhibitors Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by PDE Inhibitors Revenue in 2019
- 3.2.5 Global PDE Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 PDE Inhibitors Price by Manufacturers
- 3.4 PDE Inhibitors Manufacturing Base Distribution, Product Types
- 3.4.1 PDE Inhibitors Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers PDE Inhibitors Product Type
- 3.4.3 Date of International Manufacturers Enter into PDE Inhibitors Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global PDE Inhibitors Market Size by Type (2015-2020)
- 4.1.1 Global PDE Inhibitors Sales by Type (2015-2020)
- 4.1.2 Global PDE Inhibitors Revenue by Type (2015-2020)
- 4.1.3 PDE Inhibitors Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global PDE Inhibitors Market Size Forecast by Type (2021-2026)
- 4.2.1 Global PDE Inhibitors Sales Forecast by Type (2021-2026)
- 4.2.2 Global PDE Inhibitors Revenue Forecast by Type (2021-2026)
- 4.2.3 PDE Inhibitors Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global PDE Inhibitors Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global PDE Inhibitors Market Size by Application (2015-2020)
- 5.1.1 Global PDE Inhibitors Sales by Application (2015-2020)
- 5.1.2 Global PDE Inhibitors Revenue by Application (2015-2020)
- 5.1.3 PDE Inhibitors Price by Application (2015-2020)
- 5.2 PDE Inhibitors Market Size Forecast by Application (2021-2026)
- 5.2.1 Global PDE Inhibitors Sales Forecast by Application (2021-2026)
- 5.2.2 Global PDE Inhibitors Revenue Forecast by Application (2021-2026)
- 5.2.3 Global PDE Inhibitors Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America PDE Inhibitors by Country
- 6.1.1 North America PDE Inhibitors Sales by Country
- 6.1.2 North America PDE Inhibitors Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America PDE Inhibitors Market Facts & Figures by Type
- 6.3 North America PDE Inhibitors Market Facts & Figures by Application
7 Europe
- 7.1 Europe PDE Inhibitors by Country
- 7.1.1 Europe PDE Inhibitors Sales by Country
- 7.1.2 Europe PDE Inhibitors Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe PDE Inhibitors Market Facts & Figures by Type
- 7.3 Europe PDE Inhibitors Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific PDE Inhibitors by Region
- 8.1.1 Asia Pacific PDE Inhibitors Sales by Region
- 8.1.2 Asia Pacific PDE Inhibitors Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific PDE Inhibitors Market Facts & Figures by Type
- 8.3 Asia Pacific PDE Inhibitors Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America PDE Inhibitors by Country
- 9.1.1 Latin America PDE Inhibitors Sales by Country
- 9.1.2 Latin America PDE Inhibitors Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America PDE Inhibitors Market Facts & Figures by Type
- 9.3 Central & South America PDE Inhibitors Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa PDE Inhibitors by Country
- 10.1.1 Middle East and Africa PDE Inhibitors Sales by Country
- 10.1.2 Middle East and Africa PDE Inhibitors Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 UAE
- 10.2 Middle East and Africa PDE Inhibitors Market Facts & Figures by Type
- 10.3 Middle East and Africa PDE Inhibitors Market Facts & Figures by Application
11 Company Profiles
- 11.1 Hanmi Science Holding
- 11.1.1 Hanmi Science Holding Corporation Information
- 11.1.2 Hanmi Science Holding Description and Business Overview
- 11.1.3 Hanmi Science Holding Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Hanmi Science Holding PDE Inhibitors Products Offered
- 11.1.5 Hanmi Science Holding Related Developments
- 11.2 Boehringer Ingelheim
- 11.2.1 Boehringer Ingelheim Corporation Information
- 11.2.2 Boehringer Ingelheim Description and Business Overview
- 11.2.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Boehringer Ingelheim PDE Inhibitors Products Offered
- 11.2.5 Boehringer Ingelheim Related Developments
- 11.3 Takeda Pharmaceuticals
- 11.3.1 Takeda Pharmaceuticals Corporation Information
- 11.3.2 Takeda Pharmaceuticals Description and Business Overview
- 11.3.3 Takeda Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Takeda Pharmaceuticals PDE Inhibitors Products Offered
- 11.3.5 Takeda Pharmaceuticals Related Developments
- 11.4 AstraZeneca
- 11.4.1 AstraZeneca Corporation Information
- 11.4.2 AstraZeneca Description and Business Overview
- 11.4.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 AstraZeneca PDE Inhibitors Products Offered
- 11.4.5 AstraZeneca Related Developments
- 11.5 Bayer
- 11.5.1 Bayer Corporation Information
- 11.5.2 Bayer Description and Business Overview
- 11.5.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Bayer PDE Inhibitors Products Offered
- 11.5.5 Bayer Related Developments
- 11.6 Celgene
- 11.6.1 Celgene Corporation Information
- 11.6.2 Celgene Description and Business Overview
- 11.6.3 Celgene Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Celgene PDE Inhibitors Products Offered
- 11.6.5 Celgene Related Developments
- 11.7 Eli Lilly
- 11.7.1 Eli Lilly Corporation Information
- 11.7.2 Eli Lilly Description and Business Overview
- 11.7.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Eli Lilly PDE Inhibitors Products Offered
- 11.7.5 Eli Lilly Related Developments
- 11.8 Pfizer
- 11.8.1 Pfizer Corporation Information
- 11.8.2 Pfizer Description and Business Overview
- 11.8.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Pfizer PDE Inhibitors Products Offered
- 11.8.5 Pfizer Related Developments
- 11.9 BioCrea
- 11.9.1 BioCrea Corporation Information
- 11.9.2 BioCrea Description and Business Overview
- 11.9.3 BioCrea Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 BioCrea PDE Inhibitors Products Offered
- 11.9.5 BioCrea Related Developments
- 11.10 Dart NeuroScience
- 11.10.1 Dart NeuroScience Corporation Information
- 11.10.2 Dart NeuroScience Description and Business Overview
- 11.10.3 Dart NeuroScience Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Dart NeuroScience PDE Inhibitors Products Offered
- 11.10.5 Dart NeuroScience Related Developments
- 11.1 Hanmi Science Holding
- 11.1.1 Hanmi Science Holding Corporation Information
- 11.1.2 Hanmi Science Holding Description and Business Overview
- 11.1.3 Hanmi Science Holding Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Hanmi Science Holding PDE Inhibitors Products Offered
- 11.1.5 Hanmi Science Holding Related Developments
- 11.12 CTC Bio
- 11.12.1 CTC Bio Corporation Information
- 11.12.2 CTC Bio Description and Business Overview
- 11.12.3 CTC Bio Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 CTC Bio Products Offered
- 11.12.5 CTC Bio Related Developments
- 11.13 FORUM Pharmaceuticals
- 11.13.1 FORUM Pharmaceuticals Corporation Information
- 11.13.2 FORUM Pharmaceuticals Description and Business Overview
- 11.13.3 FORUM Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 FORUM Pharmaceuticals Products Offered
- 11.13.5 FORUM Pharmaceuticals Related Developments
- 11.14 Intra-Cellular Therapies
- 11.14.1 Intra-Cellular Therapies Corporation Information
- 11.14.2 Intra-Cellular Therapies Description and Business Overview
- 11.14.3 Intra-Cellular Therapies Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 Intra-Cellular Therapies Products Offered
- 11.14.5 Intra-Cellular Therapies Related Developments
- 11.15 Omeros Corporation
- 11.15.1 Omeros Corporation Corporation Information
- 11.15.2 Omeros Corporation Description and Business Overview
- 11.15.3 Omeros Corporation Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 Omeros Corporation Products Offered
- 11.15.5 Omeros Corporation Related Developments
- 11.16 Medimetriks Pharmaceuticals
- 11.16.1 Medimetriks Pharmaceuticals Corporation Information
- 11.16.2 Medimetriks Pharmaceuticals Description and Business Overview
- 11.16.3 Medimetriks Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.16.4 Medimetriks Pharmaceuticals Products Offered
- 11.16.5 Medimetriks Pharmaceuticals Related Developments
- 11.17 NuSirt Biopharma
- 11.17.1 NuSirt Biopharma Corporation Information
- 11.17.2 NuSirt Biopharma Description and Business Overview
- 11.17.3 NuSirt Biopharma Sales, Revenue and Gross Margin (2015-2020)
- 11.17.4 NuSirt Biopharma Products Offered
- 11.17.5 NuSirt Biopharma Related Developments
- 11.18 Palobiopharma
- 11.18.1 Palobiopharma Corporation Information
- 11.18.2 Palobiopharma Description and Business Overview
- 11.18.3 Palobiopharma Sales, Revenue and Gross Margin (2015-2020)
- 11.18.4 Palobiopharma Products Offered
- 11.18.5 Palobiopharma Related Developments
- 11.19 Roivant Sciences
- 11.19.1 Roivant Sciences Corporation Information
- 11.19.2 Roivant Sciences Description and Business Overview
- 11.19.3 Roivant Sciences Sales, Revenue and Gross Margin (2015-2020)
- 11.19.4 Roivant Sciences Products Offered
- 11.19.5 Roivant Sciences Related Developments
- 11.20 Sagene Pharmaceuticals
- 11.20.1 Sagene Pharmaceuticals Corporation Information
- 11.20.2 Sagene Pharmaceuticals Description and Business Overview
- 11.20.3 Sagene Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.20.4 Sagene Pharmaceuticals Products Offered
- 11.20.5 Sagene Pharmaceuticals Related Developments
- 11.21 Tetra Discovery Partners
- 11.21.1 Tetra Discovery Partners Corporation Information
- 11.21.2 Tetra Discovery Partners Description and Business Overview
- 11.21.3 Tetra Discovery Partners Sales, Revenue and Gross Margin (2015-2020)
- 11.21.4 Tetra Discovery Partners Products Offered
- 11.21.5 Tetra Discovery Partners Related Developments
- 11.22 Tritech Biopharm
- 11.22.1 Tritech Biopharm Corporation Information
- 11.22.2 Tritech Biopharm Description and Business Overview
- 11.22.3 Tritech Biopharm Sales, Revenue and Gross Margin (2015-2020)
- 11.22.4 Tritech Biopharm Products Offered
- 11.22.5 Tritech Biopharm Related Developments
- 11.23 Otsuka
- 11.23.1 Otsuka Corporation Information
- 11.23.2 Otsuka Description and Business Overview
- 11.23.3 Otsuka Sales, Revenue and Gross Margin (2015-2020)
- 11.23.4 Otsuka Products Offered
- 11.23.5 Otsuka Related Developments
- 11.24 Chiesi Farmaceutici
- 11.24.1 Chiesi Farmaceutici Corporation Information
- 11.24.2 Chiesi Farmaceutici Description and Business Overview
- 11.24.3 Chiesi Farmaceutici Sales, Revenue and Gross Margin (2015-2020)
- 11.24.4 Chiesi Farmaceutici Products Offered
- 11.24.5 Chiesi Farmaceutici Related Developments
- 11.25 Verona Pharma
- 11.25.1 Verona Pharma Corporation Information
- 11.25.2 Verona Pharma Description and Business Overview
- 11.25.3 Verona Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.25.4 Verona Pharma Products Offered
- 11.25.5 Verona Pharma Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 PDE Inhibitors Market Estimates and Projections by Region
- 12.1.1 Global PDE Inhibitors Sales Forecast by Regions 2021-2026
- 12.1.2 Global PDE Inhibitors Revenue Forecast by Regions 2021-2026
- 12.2 North America PDE Inhibitors Market Size Forecast (2021-2026)
- 12.2.1 North America: PDE Inhibitors Sales Forecast (2021-2026)
- 12.2.2 North America: PDE Inhibitors Revenue Forecast (2021-2026)
- 12.2.3 North America: PDE Inhibitors Market Size Forecast by Country (2021-2026)
- 12.3 Europe PDE Inhibitors Market Size Forecast (2021-2026)
- 12.3.1 Europe: PDE Inhibitors Sales Forecast (2021-2026)
- 12.3.2 Europe: PDE Inhibitors Revenue Forecast (2021-2026)
- 12.3.3 Europe: PDE Inhibitors Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific PDE Inhibitors Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: PDE Inhibitors Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: PDE Inhibitors Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: PDE Inhibitors Market Size Forecast by Region (2021-2026)
- 12.5 Latin America PDE Inhibitors Market Size Forecast (2021-2026)
- 12.5.1 Latin America: PDE Inhibitors Sales Forecast (2021-2026)
- 12.5.2 Latin America: PDE Inhibitors Revenue Forecast (2021-2026)
- 12.5.3 Latin America: PDE Inhibitors Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa PDE Inhibitors Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: PDE Inhibitors Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: PDE Inhibitors Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: PDE Inhibitors Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key PDE Inhibitors Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 PDE Inhibitors Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on PDE Inhibitors. Industry analysis & Market Report on PDE Inhibitors is a syndicated market report, published as Global PDE Inhibitors Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of PDE Inhibitors market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
